Site icon pharmaceutical daily

AmerisourceBergen Releases 2021 Global Sustainability Report to Share Progress and Impact on Environmental, Social and Governance Priorities

CONSHOHOCKEN, Pa.–(BUSINESS WIRE)–AmerisourceBergen, a global healthcare company, released its 2021 Global Sustainability Report and Environmental, Social and Governance (ESG) Reporting Index, detailing the impact of its robust sustainability and community efforts. The report and ESG Reporting Index, which are available through a microsite, highlight AmerisourceBergen’s commitment to corporate responsibility and global sustainability and contain detailed information on ESG performance. For the fourth year in a row, selected information within the 2021 report was assured by ERM Certification and Verification Services.

“At AmerisourceBergen, we recognize the opportunity we have to advance initiatives that protect our planet and improve the wellbeing of people worldwide,” said Gina Clark, EVP, Chief Communications & Administration Officer at AmerisourceBergen. “As we expand our global footprint, our responsibility as stewards focused on sustainability and health equity grows exponentially. We’ve leaned into this opportunity and continue to prioritize efforts and partnerships that improve access and equity in healthcare, create more sustainable operations across the supply chain and inspire team members to achieve their potential. We look forward to building upon the progress we’ve made as we continue to fulfill our promise of strong global sustainability.”

The Corporate Responsibility and Global Sustainability strategy focuses on key priorities that align with the services and beliefs at AmerisourceBergen. The 2021 report and microsite detail several notable milestones, including initiatives led by Alliance Healthcare, a leading pharmaceutical wholesaler in Europe which AmerisourceBergen acquired in 2021. The highlights include:

COVID-19 Response: The role of AmerisourceBergen in the healthcare supply chain has never been more critical than during a global pandemic. AmerisourceBergen continued to deliver more than four million products daily to providers serving human and animal patients, while also supporting the distribution of COVID-19 therapies and vaccines and prioritizing solutions to support the well-being of team members around the world. Specific initiatives include:

Purpose-Driven Team Members: AmerisourceBergen engages team members and fosters a diverse and inclusive global workforce. The company strives to provide a safe, supportive work environment where team members can thrive, the company’s purpose is shared, and individuality is celebrated. Specific initiatives in 2021 included:

Resilient and Sustainable Operations: As part of its commitment to efficient and responsible operations across the supply chain, AmerisourceBergen continues to deploy solutions that improve efficiency and product safety and enable the company to create a more sustainable footprint. Highlights include:

Healthy Communities for All: AmerisourceBergen strives to support equitable access to healthcare services in communities worldwide by making programs and medication accessible where needed most. Highlights include:

For more information on the 2021 Global Sustainability Report, please visit: https://sustainability.amerisourcebergen.com/

In addition to external assurance and verification, this report has been prepared in accordance with the Global Reporting Initiative (GRI) Standards: Core option. This ESG Reporting Index is aligned with the Sustainability Accounting Standards Board (SASB), Task Force on Climate-related Financial Disclosures (TCFD), World Economic Forum (WEF) Stakeholder Capitalism Metrics, and the United Nations Sustainable Development Goals (UNSDGs).

AmerisourceBergen’s continued progress and commitment to advancing ESG initiatives is reflected by the company’s inclusion in the S&P Global Sustainability Yearbook 2022, one of the most comprehensive publications providing in-depth analysis on corporate sustainability. AmerisourceBergen, which was one of the more than 7,000 companies assessed by S&P Global, scored within the top 15 percent of its industry and achieved an S&P Global ESG score within 30 percent of the industry’s top-performing. AmerisourceBergen was also recently named one of “America’s Most Responsible Companies” by Newsweek magazine.

About AmerisourceBergen

AmerisourceBergen fosters a positive impact on the health of people and communities around the world by advancing the development and delivery of pharmaceuticals and healthcare products. As a leading global healthcare company, with a foundation in pharmaceutical distribution and solutions for manufacturers, pharmacies, and providers, we create unparalleled access, efficiency, and reliability for human and animal health. Our 42,000 global team members power our purpose: We are united in our responsibility to create healthier futures. AmerisourceBergen is ranked #8 on the Fortune 500 with more than $200 billion in annual revenue. Learn more at https://amerisourcebergen.com/.

Contacts

Mike Iorfino, AmerisourceBergen

610-545-9189 – Mobile

Mike.Iorfino@amerisourcebergen.com

Exit mobile version